Sign in

CIK 0001125345

  • Non-accelerated filer
  • Smaller reporting company

MACROGENICS INC

Sign in to watch
Ticker
MGNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 301-251-5172
Business address
9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-29 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +500 $1.51 $755 44,968
2020-12-29 Risser Eric Blasius Sr VP & Chief Business Officer Sale −500 $24.10 $12K 44,468
2020-12-29 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −500 8,500
2020-11-30 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +500 $1.51 $755 44,968
2020-11-30 Risser Eric Blasius Sr VP & Chief Business Officer Sale −500 $23.35 $12K 44,468
2020-11-30 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −500 9,000
2020-10-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +1,500 $1.51 $2K 45,968
2020-10-28 Risser Eric Blasius Sr VP & Chief Business Officer Sale −1,500 $20.69 $31K 44,468
2020-10-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −1,500 9,500
2020-09-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion +500 $1.51 $755 44,968
2020-09-28 Risser Eric Blasius Sr VP & Chief Business Officer Sale −500 $25.33 $13K 44,468
2020-09-28 Risser Eric Blasius Sr VP & Chief Business Officer Exercise or conversion · Employee stock option (right to buy) −500 11,000
2020-09-18 Bonvini Ezio Sr VP, Research & CSO Sale −18,339 $32.00 $587K 83,807
2020-09-17 Bonvini Ezio Sr VP, Research & CSO Sale −44,512 $29.88 $1.3M 102,146
2020-09-09 Galbraith Kenneth Director Exercise or conversion +13,849 $16.00 $222K 13,849
2020-09-09 Galbraith Kenneth Director Sale −13,849 $27.11 $375K 0
2020-09-09 Galbraith Kenneth Director Exercise or conversion +6,924 $20.15 $140K 6,924
2020-09-09 Galbraith Kenneth Director Sale −6,924 $27.11 $188K 0
2020-09-09 Galbraith Kenneth Director Exercise or conversion · Stock Option (right to buy) −13,849 0
2020-09-09 Galbraith Kenneth Director Exercise or conversion · Stock Option (right to buy) −6,924 0

Page 25 of 26 · 503 trades